| 000 | 01664 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515221926.0 | ||
| 264 | 0 | _c20101013 | |
| 008 | 201010s 0 0 eng d | ||
| 022 | _a1873-4596 | ||
| 024 | 7 |
_a10.1016/j.freeradbiomed.2010.04.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Chang-Jun | |
| 245 | 0 | 0 |
_aImpaired dephosphorylation renders G6PD-knockdown HepG2 cells more susceptible to H(2)O(2)-induced apoptosis. _h[electronic resource] |
| 260 |
_bFree radical biology & medicine _cAug 2010 |
||
| 300 |
_a361-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
| 650 | 0 | 4 |
_aAnthracenes _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aDual Specificity Phosphatase 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aFlavonoids _xpharmacology |
| 650 | 0 | 4 | _aGene Knockdown Techniques |
| 650 | 0 | 4 |
_aGlucosephosphate Dehydrogenase _xgenetics |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProtein Tyrosine Phosphatases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 700 | 1 | _aHo, Hung-Yao | |
| 700 | 1 | _aCheng, Mei-Ling | |
| 700 | 1 | _aYou, Tsai-Hong | |
| 700 | 1 | _aCheng, Tsai-Hong | |
| 700 | 1 | _aYu, Jau-Song | |
| 700 | 1 | _aChiu, Daniel Tsun-Yee | |
| 773 | 0 |
_tFree radical biology & medicine _gvol. 49 _gno. 3 _gp. 361-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.freeradbiomed.2010.04.019 _zAvailable from publisher's website |
| 999 |
_c19777973 _d19777973 |
||